充血性心力衰竭 - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

Abstract

Phenotypic Refinement of Heart Failure in a National Biobank Facilitates Genetic Discovery
Frailty Is Intertwined With Heart Failure: Mechanisms, Prevalence, Prognosis, Assessment, and Management
Association of loop diuretics use and dose with outcomes in outpatients with heart failure: a systematic review and meta-analysis of observational studies involving 96,959 patients
Circulating sST2 and catestatin levels in patients with acute worsening of heart failure: a report from the CATSTAT-HF study
Nitrosative stress drives heart failure with preserved ejection fraction
Cardiac Resynchronization Therapy and Ventricular Tachyarrhythmia Burden
Effects of Dapagliflozin on Symptoms, Function and Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction: Results from the DAPA-HF Trial
Diuretic Therapy for Patients With Heart Failure JACC State-of-the-Art Review
Risk of Mortality Following Catheter Ablation of Atrial Fibrillation
The spectrum of heart failure: value of left ventricular ejection fraction and its moving trajectories

Clinical Trial

Nov. 17, 2019

JOURNAL：Circulation.

Effects of Dapagliflozin on Symptoms, Function and Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction: Results from the DAPA-HF Trial

MN Kosiborod, PJhund, KF Docherty et al.

4439

Keywords: dapagliflozin; HFrEF; quality of life; cardiovascular outcomes

FULL TEXT PDF